SS Innovations International, Inc., is a commercial-stage surgical robotics company in India and internationally. The company is headquartered in Gurugram, India.
| Revenue (TTM) | $52.41M |
| Gross Profit (TTM) | $24.97M |
| EBITDA | $-7.19M |
| Operating Margin | -16.30% |
| Return on Equity | -26.10% |
| Return on Assets | -6.34% |
| Revenue/Share (TTM) | $0.27 |
| Book Value | $0.27 |
| Price-to-Book | 14.56 |
| Price-to-Sales (TTM) | 14.38 |
| EV/Revenue | 14.92 |
| EV/EBITDA | -24.73 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 39.40% |
| Shares Outstanding | $200.38M |
| Float | $40.32M |
| % Insiders | 80.11% |
| % Institutions | 0.85% |
Volatility is currently contracting
Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales
Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event
Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth
New course empowers healthcare professionals through expert instruction and hands-on learning New course empowers healthcare professionals through expert instruction and hands-on learning
AUSTIN, Texas, July 07, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, has engaged IBN , a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.
Company celebrated for advancing global access to its innovative robotic surgery platform Company celebrated for advancing global access to its innovative robotic surgery platform
SS Innovations (SSII) posted another quarter where revenue more than doubled compared to the prior year. Consistent sequential revenue acceleration highlights strong operational momentum following similar Q4 FY25 performance. Potential US and European regulatory approval provide significant asymmetric reward.
FORT LAUDERDALE, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that a robot-assisted heart procedure was successfully performed with the SSi Mantra surgical robotic system (the “SSi Mantra”) across approximately 12,500 miles (20,000 kilometers) of fiber network distance between Guyana and India, making it the world's longest-distance robotic telesurgery ever conducted.
Board Appointment Enhances UberDoc's Strategic Positioning in the Rapidly Growing Direct-Pay Healthcare Market Boston, Massachusetts--(Newsfile Corp. - May 19, 2026) - UBERDOC Health Technologies (CSE: APPT) (FSE: 4KL0) is pleased to announce the appointment of John Dvor to its Board of Directors as the company continues to scale its nationwide direct-pay specialty care marketplace and expand strategic partnerships in advanced medical services and technologies. John Dvor brings deep experience and extensive relationships across medical innovation, healthcare technology, advanced therapeutics, cancer care, longevity medicine, and pharmacogenetics – particularly within the rapidly growing direct-pay healthcare sector.
FORT LAUDERDALE, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three months ended March 31, 2026.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SSII and any ticker you trade — then tracks every position and per-strategy win rate.
